These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35903095)
1. Single-Cell Transcriptomic Analysis Reveals the Crosstalk Propensity Between the Tumor Intermediate State and the CD8+ T Exhausted State to be Associated with Clinical Benefits in Melanoma. Zhu J; Yan M; Yan H; Xu L; Jiang Z; Liao G; Zhou Y; Liu W; Liang X; Li X; Xiao Y; Zhang Y Front Immunol; 2022; 13():766852. PubMed ID: 35903095 [TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer. Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241 [TBL] [Abstract][Full Text] [Related]
3. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma. Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X Front Immunol; 2021; 12():758288. PubMed ID: 34804045 [TBL] [Abstract][Full Text] [Related]
4. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq. Carmona SJ; Siddiqui I; Bilous M; Held W; Gfeller D Oncoimmunology; 2020; 9(1):1737369. PubMed ID: 32313720 [TBL] [Abstract][Full Text] [Related]
5. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma. Sade-Feldman M; Yizhak K; Bjorgaard SL; Ray JP; de Boer CG; Jenkins RW; Lieb DJ; Chen JH; Frederick DT; Barzily-Rokni M; Freeman SS; Reuben A; Hoover PJ; Villani AC; Ivanova E; Portell A; Lizotte PH; Aref AR; Eliane JP; Hammond MR; Vitzthum H; Blackmon SM; Li B; Gopalakrishnan V; Reddy SM; Cooper ZA; Paweletz CP; Barbie DA; Stemmer-Rachamimov A; Flaherty KT; Wargo JA; Boland GM; Sullivan RJ; Getz G; Hacohen N Cell; 2018 Nov; 175(4):998-1013.e20. PubMed ID: 30388456 [TBL] [Abstract][Full Text] [Related]
7. 9-Gene Signature Correlated With CD8 Yan K; Lu Y; Yan Z; Wang Y Front Immunol; 2021; 12():622563. PubMed ID: 34220795 [TBL] [Abstract][Full Text] [Related]
8. Dissecting cellular states of infiltrating microenvironment cells in melanoma by integrating single-cell and bulk transcriptome analysis. Shi A; Yan M; Pang B; Pang L; Wang Y; Lan Y; Zhang X; Xu J; Ping Y; Hu J BMC Immunol; 2023 Dec; 24(1):52. PubMed ID: 38082384 [TBL] [Abstract][Full Text] [Related]
9. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells. Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672 [TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis. Huang L; Chen H; Xu Y; Chen J; Liu Z; Xu Q Cancer Med; 2020 Nov; 9(22):8444-8456. PubMed ID: 32931642 [TBL] [Abstract][Full Text] [Related]
11. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Li H; van der Leun AM; Yofe I; Lubling Y; Gelbard-Solodkin D; van Akkooi ACJ; van den Braber M; Rozeman EA; Haanen JBAG; Blank CU; Horlings HM; David E; Baran Y; Bercovich A; Lifshitz A; Schumacher TN; Tanay A; Amit I Cell; 2019 Feb; 176(4):775-789.e18. PubMed ID: 30595452 [TBL] [Abstract][Full Text] [Related]
12. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment. Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554 [TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA-sequencing analyses identify heterogeneity of CD8 Deng W; Ma Y; Su Z; Liu Y; Liang P; Huang C; Liu X; Shao J; Zhang Y; Zhang K; Chen J; Li R Mol Ther Oncolytics; 2021 Mar; 20():105-118. PubMed ID: 33575475 [TBL] [Abstract][Full Text] [Related]
14. B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade. Singh S; Roszik J; Saini N; Singh VK; Bavisi K; Wang Z; Vien LT; Yang Z; Kundu S; Davis RE; Bover L; Diab A; Neelapu SS; Overwijk WW; Rai K; Singh M Front Immunol; 2022; 13():794684. PubMed ID: 35720386 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients. Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z Front Immunol; 2021; 12():659444. PubMed ID: 34040608 [TBL] [Abstract][Full Text] [Related]
16. Potential crosstalk between SPP1 + TAMs and CD8 + exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer. Du Y; Lin Y; Gan L; Wang S; Chen S; Li C; Hou S; Hu B; Wang B; Ye Y; Shen Z J Transl Med; 2024 Feb; 22(1):158. PubMed ID: 38365757 [TBL] [Abstract][Full Text] [Related]
17. Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice. Zhang C; Lei L; Yang X; Ma K; Zheng H; Su Y; Jiao A; Wang X; Liu H; Zou Y; Shi L; Zhou X; Sun C; Hou Y; Xiao Z; Zhang L; Zhang B J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642245 [TBL] [Abstract][Full Text] [Related]
18. CXCR6 is required for antitumor efficacy of intratumoral CD8 Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326 [TBL] [Abstract][Full Text] [Related]
19. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression. Andersen R; Borch TH; Draghi A; Gokuldass A; Rana MAH; Pedersen M; Nielsen M; Kongsted P; Kjeldsen JW; Westergaard MCW; Radic HD; Chamberlain CA; Hölmich LR; Hendel HW; Larsen MS; Met Ö; Svane IM; Donia M Ann Oncol; 2018 Jul; 29(7):1575-1581. PubMed ID: 29688262 [TBL] [Abstract][Full Text] [Related]
20. The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer. Long F; Wang W; Li S; Wang B; Hu X; Wang J; Xu Y; Liu M; Zhou J; Si H; Xi X; Meng XY; Yuan C; Wang F J Transl Med; 2023 May; 21(1):298. PubMed ID: 37138324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]